However, if your logo-creating needs are simple, Hatchful’s offering could be for you. After running through the process, you'll come out the other side with high-resolution images suitable for ...

A 3D logo is a development of the flat logo because it has depth and texture and is consequently three-dimensional. These logos seem more active and appealing to the viewer, providing a contemporary ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

However, on the same day, Wells Fargo maintained a Hold rating on Biogen (NASDAQ: BIIB). The company has a one-year high of $238.00 and a one-year low of $128.51. Currently, Biogen has an average ...

However, today, Wells Fargo maintained a Hold rating on Biogen (NASDAQ: BIIB). The company has a one-year high of $238.00 and a one-year low of $128.51. Currently, Biogen has an average volume of ...

NASDAQ BIIB opened at $138.45 on Friday. Biogen has a fifty-two week low of $128.51 and a fifty-two week high of $238.00. The firm’s fifty day moving average price is $147.73 and its two-hundred ...

The company’s 50-day moving average price is $147.31 and its 200-day moving average price is $173.80. Biogen has a twelve month low of $128.51 and a twelve month high of $238.00. The company has ...

stating it "significantly undervalues" the company and does not serve shareholders' best interests. Biogen, which currently holds a 10.2% stake in Sage, proposed to acquire all outstanding Sage ...

(Reuters) -Sage Therapeutics said on Monday that its board has unanimously rejected Biogen’s $469 million offer, stating it "significantly undervalues" the company and does not serve ...

Biogen shares fell, after the biotechnology company forecast lower-than-expected revenue and profit for this year, saying multiple-sclerosis drug sales will decline further and will only be partially ...

If the pathway to Alzheimer’s diagnosis and treatment does not begin to improve rapidly, Biogen’s high-risk investment ... and we have a mixed view on the company's distribution strategy.